June 18, 2025

ABOUT THIS EPISODE

Exploring the Endocannabinoid System: A New Era in Therapy

EP3 - In this special edition episode, Releaf COO Graham Woodward sits down with cannabinoid pharmacologist Professor Saoirse O’Sullivan to explore whether our current approach to cannabis-based treatment is truly evidence-led or built on outdated myths.

From the science behind THC and CBD to the truth about the entourage effect, this episode challenges assumptions and asks what it takes to get cannabis medicine right.

Spotify Video Chapters:

00:00 Beyond The Script with Saoirse O’Sullivan

01:00 Understanding the Endocannabinoid System

03:07 Tailoring Treatments with Cannabinoid Science

04:35 Exploring Minor Phytocannabinoids

07:10 Real-World Evidence and Clinical Trials

09:18 Pharmaceutical Insights and Future Directions

17:02 The Entourage Effect

19:23 Future of Cannabinoid Treatments

23:33 Conclusion and Final Thoughts

Medicine

Science

Health & Fitness

Medicine

Life Sciences

Business

English

United States

Use API to fetch this episode in JSON

IN THIS EPISODE

graham woodward

Edit these tags

TRANSCRIPT 🔗

Are you the producer of this podcast? Add a podcast transcript

Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SEARCH PAST EPISODES

Search past episodes of Beyond The Script.

Embed this search bar to your website

OTHER EPISODES IN THIS PODCAST

Unlocking the Medical Cannabis Market: Revolutionising Access and Innovation

June 20, 2025

EP4 - Tim Kirby, CEO of Releaf and Michael Sassano, CEO and Chairman of the Board with SOMAÍ Pharmaceuticals discuss strategies for expanding the medical cannabis market in the UK. They highlight the challenges in the current market, such as patient accessibility and supply chain issues, emph…

00:37:24

SAVE

CLIP

The UK's Largest Ever Medical Cannabis Deal

June 9, 2025

EP1 - CEOs Tim Kirby of Releaf and James Duckenfield of Glass Pharm sat down to discuss the ever-evolving UK medical cannabis sector. In 2024, we joined forces with Glass Pharms in the UK's largest ever medical cannabis deal, providing Releaf patients with a consistent, high-quality supply of…

00:52:29

SAVE

CLIP

From Anecdote to Evidence: Using Data for Advanced Access | Releaf & Dr Anne Katrin Schlag

July 10, 2025

EP5 - Join COO of Releaf, Graham Woodward, and Dr Anne Katrin Schlag, Head of Research at Drug Science, as they explore how the UK can move from anecdotal patient stories to real-world evidence, and why this shift is vital for expanding safe, trusted access to cannabis-based medicines. Let's rethin…

00:26:40

SAVE

CLIP

Power, Politics and the Future of UK Medical Cannabis

June 11, 2025

EP2 - Robert Jappie, partner at Fieldfisher LLP and Tim Kirby, CEO at Releaf unpack the challenges and opportunities shaping the UK’s medical cannabis landscape, from the slow-moving regulatory environment to the urgent need for patient-focused innovation. Key topics include: - Why the UK's medical…

00:37:57

SAVE

CLIP

Disclaimer: The podcast and artwork embedded on this page are from Releaf, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.